Histolog® Scanner presented at the ESSO39 congress
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the oncology surgeon community during the 2019…
Histolog® Scanner at the AFIB 2019 congress
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the biomedical engineers community during the 24th…
Participation to the Convergence in Oncology Summit
Mr Bastien Rachet, CEO of SamanTree Medical, will participate as speaker during the 2019 Convergence in Oncology Summit ! The Summit will…
Ambitious study started at Gustave Roussy
The Histolog Scanner will be used on several hundreds of breast cancer surgical specimens involving breast surgeons and pathologists. This…
Promising results on breast biopsies published
"The Histolog Scanner offers great potential for immediate margin analysis of specimen in breast conserving therapy." A recently published…
SamanTree Medical raises CHF 9.5 million to assess the margins in cancer surgery
Following the promising clinical results achieved with its CE mark device, SamanTree Medical has recently closed a CHF 9.5 Million Series A…
CE Mark for Histolog™ Scanner new version
Latest version of the Histolog™ Scanner obtained the CE Mark for compliance with European Directives. The product has been upgraded to suit…
H2020 EU grant for market entry
European Innovation Council of the European Union supports Histolog™ Scanner market entry with €2.3 millions grant, via its H2020 SME's…
FIT loan to support market entry
SamanTree Medical has been granted a loan of CHF 400’000 by the Foundation for Technological Innovation (FIT) to support the Histolog…
The Histolog™ Scanner presented at the ParisBreast Rendez-Vous 2018
SamanTree Medical is pleased to announce that the Histolog™ Scanner will be showcased to the breast surgeon community during the "Paris…